The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
Due to the threat of the ongoing coronavirus pandemic, this year’s AACC Annual Scientific Meeting & Clinical Lab Expo is held as a virtual event on December 13-17.
At the 2020 AACC Annual Scientific Meeting, you will have an unparalleled opportunity to discover Wondfo’s vital innovations in rapid diagnosis. We sincerely welcome you and your company representatives to visit our eBooth from December 13-17.
Wondfo USA is a branch of Guangzhou Wondfo Biotech Co., Ltd. located in the United States. Wondfo USA distributes rapid drug testing kits as well as other POCT products manufactured by its parent company. Guangzhou Wondfo Biotech Co., Ltd is a globally recognized fast-growing POCT manufacturer specialized in R&D, manufacture, and sales of rapid diagnostic tests and related medical devices for in vitro diagnostics.
We cordially invite you to attend the exhibition to have a deep communication upon our products and solutions at the exhibition and expect to establish long-term business relationships with your company in the near future.
Yours sincerely,
Guangzhou Wondfo Biotech Co., Ltd. & Wondfo USA Co., Ltd